 |
|
Researcher Profile - Donald Addington |
|
|
|
| First Name: | Donald | | Last Name: | Addington | | Title: | Dr. | | Advanced Degrees: | MBBS | | Affiliation: | University of Calgary | | Department: | Psychiatry | | Street Address 1: | Foothills Hospital Department of Psychiatry | | Street Address 2: | 1403 29th Street NW | | City: | Calgary | | State/Province: | Alberta | | Zip/Postal Code: | T2N 2T9 | Country/Territory: | Canada | | Phone: | 403-944-1296 | | Fax: | 403-270-3451 | | Email Address: |  |
Disclosure:
(view policy) |
Member reports no financial or other potential conflicts of interest. [Last Modified: 17 January 2006]
|
I have 20 years experience as a clinical researcher with interests in phenomenology, pharmacotherapy and health care services research. |
Addington D, Addington J, Schissel B. Related Articles, Links
A depression rating scale for schizophrenics.
Schizophr Res. 1990 Jul-Aug;3(4):247-51
Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, Beauclair L
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia.
Addington D. The use of placebos in clinical trials for acute schizophrenia.
Can J Psychiatry. 1995 May;40(4):171-6. Review.
PMID: 7621385 [PubMed - indexed for MEDLINE
Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. Related Articles, Links
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Schizophr Res. 2003 May 1;61(1):19-30.
PMID: 12648732 [PubMed - indexed for MEDLINE]
Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res. 2005 Oct 1;78(1):35-43.
Addington,D.; Mckenzie,E.; Addington,J.; Patten,S.; Smith,H.; Adair,C. Performance measures for early psychosis treatment services Psychiatric Services 2005;57(12; 1570-1582
|
1. Petersen L, Jeppesen P, Thorup A, Abel MB, Ohlenschlaeger J, Christensen TO, Krarup G, Jorgensen P, Nordentoft M: A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. Br Med J 2005; 331(7517):602
Ref ID: 3000
2. Committee on crossing the quality chasm: Adaptation for mental health and addictive disorders. Improving the quality of health care for mental and substance-use conditions: quality chasm series. 1-600. 2005. Washington DC, National Academy of Sciences. Quality Chasm Series.
Ref Type: Report
Ref ID: 2987
3. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62(9):975-983
Ref ID: 2966
|
Intervention in pre-psychosis patients |
Neurodevelopmental hypothesis |
|
|
|
|
|
